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Abstract 
Background: Insulin has been used as a stimulatory factor for in vitro cell culture since many years. Even for routine 
in vitro embryo production (IVP), insulin is added to the media during different steps. There is a strong difference in 
concentrations used in vitro compared to what is measured in vivo in follicular fluid or serum. We performed a pilot 
study on insulin stability to explain possible reasons for that variation.
Results: We measured insulin concentrations before and after bovine oocyte maturation in an experiment by using 
a quantitative ELISA (Mercodia bovine insulin ELISA immunoassay) and found that concentrations were stable up to 
22 h of incubation. We compared our results with eleven in vivo studies measuring insulin in either serum or follicular 
fluid and nine IVP-protocols using insulin. In all studies, in vitro concentrations were much higher compared with 
those found physiologically in vivo. Limited knowledge is available concerning the different activity and stability of 
insulin in vitro versus in vivo.
Conclusions: The concentrations of insulin used in vitro are quite high in comparison to physiological concentra-
tions found in serum or follicular fluid. One explanation may be a different stability or activity of insulin in vitro even 
if we could measure stable concentrations of insulin in our pilot study. More precise dose–effect studies have to be 
performed to draw clear conclusions about the consequences of the use of such high doses as they might have 
negative consequences for the developing embryo. Insulin has direct effects on the regulation of the metabolism and 
could even influence the epigenetic programming of the metabolism with unknown consequences for the offspring 
later in life.
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Findings
In vitro production (IVP) of embryos is currently per-
formed according to standardized protocols for many 
species and for both commercial and scientific reasons. 
Oocytes are matured, fertilized and presumed zygotes are 
cultured in the laboratory until blastocyst stage. Media 
used in the laboratory usually aim to simulate the natu-
ral milieu as closely as possible, e.g. by using synthetic 
oviductal fluid (SOF) with or without serum for embryo 
culture. Different protocols use insulin as a stimulatory 
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factor (well known from cell culture as reported in 1976 
[1]) to improve embryo development rates.
We performed a pilot study with the aim of further 
investigating insulin stability in embryo production sys-
tems as there is, according to our knowledge, no clear 
evidence for the choice of the deviating concentrations 
in vitro.
The media used in our lab contains cysteine in the 
TCM199 (M2154, Sigma-Aldrich, Stockholm, Sweden).
We added insulin to the in  vitro maturation medium 
consisting of bicarbonate-buffered TCM199 (M2154) 
supplemented with 0.68  mM l-glutamine (G8540), 
0.5 µg/ml follicle-stimulating hormone (FSH) and 0.1 µg/
ml luteinizing hormone (LH) (Stimufol; PARTNAR Ani-
mal Health, Port Huron, Canada), 50  µg/ml gentamicin 
and 0.4  % w/v bovine serum albumin (BSA). Groups of 
30–45 bovine cumulus oocyte complexes (COCs) were 
matured in a separate well containing 500  µl medium 
supplemented either with 0 (INS0), 0.1  µg/ml (INS0.1) 
or 10  µg/ml (INS10) bovine insulin (I5500). All COCs 
were incubated for 22 h (24 h after the end of aspiration) 
at 38.5 °C under a 5 % O2, 5 % CO2 atmosphere. Insulin 
concentrations were analysed in three different condi-
tions: a) before maturation when the medium itself had 
been incubated around 2 h for equilibration of tempera-
ture and atmosphere and before any COCs were added 
(BM); b) after maturation with co incubation of COCs for 
22 h (AM) and c) after maturation “empty” (AME), a con-
trol containing only media without any COCs incubated 
for 22  h. The Mercodia bovine insulin ELISA Immuno-
assay for quantitative determination of bovine insulin 
in serum or plasma specially optimized for bovine sam-
ples, was used (Tables  1, 2). The two different insulin 
concentrations were used to permit the evaluation of a 
more extreme dose compared to a dose closer to physi-
ological concentrations. The study size did not allow any 
advanced statistics, only numerical result assessment. 
Stable concentrations of insulin were found as the added 
concentrations (0.1 and 10  µg/ml) related well to the 
measured concentrations after 22 h of incubation. Sum-
marizing, the results of the pilot study do not support 
the theory that insulin degradation is a reason for using 
higher insulin concentrations in in  vitro studies. How-
ever, no statements about the biological activity can be 
made based on this quantitative ELISA. 
To put our study in the context of recent research, a 
comparison to recent studies using insulin was made, 
summarized in Tables 3 and 4.
In the referred studies, insulin is added during the 22 h 
of in vitro oocyte maturation [2–6], or added to the cul-
ture medium during early embryo development [7–9]. 
Most concentrations used vary between 5 and 10  µg/
ml (Table  3). Different effects have been reported, and 
both beneficial and no significant effects on development 
have been shown. Even a change in phenotype, in form 
of increased cell numbers in the blastocyst, has been 
reported after insulin exposure during oocyte maturation 
[4, 10]. This could be a sign of accelerated growth of the 
embryos deriving from these conditions with potentially 
harmful consequences.
Several studies have been published measuring insulin 
concentrations in serum and some measuring insulin in 
follicular fluid, which generally contains hormones and 
metabolites in concentrations close to those found in 
serum [11]. The use of different analyzing methods and 
units (IU/ml; µg/ml; µM/ml) makes comparisons com-
plicated. Most of these studies report concentrations 
between 0.1 and 1 ng/ml in the bovine (Table 4). The val-
ues indicated in the tables are all transformed to the same 
units; µg/ml in Table 3, respective ng/ml in Table 4, based 
on the molecular weight of insulin 180.16 mg/mol; 1 mg 
insulin equals 25.7 or 1 IU = 0.03891 mg.
In the in  vivo situation, the developing follicle and 
maturing oocyte will have a longer exposure to metabolic 
substances such as insulin. The shortened exposure time 
Table 1 Insulin concentration in  maturation media 




Treatment Bovine insulin 
concentration 
(μg/ml)
1709 Before maturation 5
After maturation without oocytes added 4.1
After maturation with co incubation of 
oocytes
3
2711 Before maturation 4.6
After maturation with co incubation of 
oocytes
5
2611 After maturation with co incubation of 
oocytes
3.1
Table 2 Insulin concentration in  maturation media 




Treatment Bovine insulin 
concentration 
(μg/ml)
1709 Before maturation 0.24
After maturation without oocytes added 0.19
After maturation without oocytes added 0.16
2611 After maturation with co incubation of 
oocytes
0.13
2711 Before maturation 0.15
After maturation without oocytes added 0.11
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might be one factor that could explain that in vitro sys-
tems in research often are performed with higher doses 
than those found physiologically. Another explanation is 
that in general, in vitro systems have to be pushed with 
higher concentrations in order to eliminate noise of other 
influences during the investigated period.
Moreover, the use of supra-physiological doses could 
be justified by the fact that insulin has been reported 
to be quite unstable in  vitro, due to media containing 
cysteine [12]. That study demonstrated that a minimum 
concentration of 1 µg/ml was necessary to stimulate cells in 
culture resulting in a maximal stimulation 1 h post expo-
sure. Insulin action thus seems to be immediate on the cell. 
On the other hand, Spicer and Echternkamp [11] report 
an effective dose 50 (ED50) between 0.01 and 0.2  µg/ml 
(depending on the effect, as e.g. granulosa cell mitogen-
esis or estradiol production) in ovarian cell culture, which 
is closer to the physiological concentrations. These authors 
used Dulbecco’s Modified Eagle Medium and Ham’s F12 
(DMEM/F-12) medium which also contains cysteine.
Table 3 Insulin concentrations used for in vitro experiments based on published literature
IVM in vitro maturation, IVC in vitro culture, * follicular culture, BC blastocyst, (¤) ITS insulin/transferrin/sodium selenite added to serum free SOF (synthetic oviductal 
fluid, ®) reported units 1.8 pM/1.8 nM, insulin = 180.16 mg/mol, ED50 = median effective dose
Insulin during IVM (µg/ml) Insulin during IVC (µg/ml) References Main finding
10 10 [2] No effect on BC rate
5 (*) – [3] No effect on BC rate nor cell number
1 – [4] No effect on BC rate, cell number elevated
0.1/0.5/1/10 – [5] 0.5–10 μg/ml stimulated development until morula
5 (7, 12 or 22 h) – [6] Difference as different co-factor
– 5 (¤) [7] BC rates similar to those obtained by serum addition
– 5 (¤) [8] Insulin alone no beneficial effect on BC rates
– 0.01 and 10 (®) [9] Insulin no effect on BC rate nor cell number but negative 
effect on apoptosis
– ED50 0.1 for granulosa cell mitogenesis
ED50 0.01 for estradiol production
ED50 for 0.1 for progesterone production
ED50 0.2 for androgen production
[11] ED50 depends on different aspect of insulin action
Table 4 Insulin concentrations measured in follicular fluid and serum based on published literature
RIA radio immunoassay, ELISA enzyme-linked immunosorbent assay, EIA enzyme immunoassay, DELFIA dissociation-enhanced lanthanide fluoro immunoassay
Insulin in plasma (ng/ml) Insulin in follicular fluid (ng/ml) Method/kit References
0.21–0.48 – A specific double antibody RIA [13]
0.32–0.40 – 125I-labeled insulin
Double-antibody RIA
[14]










RIA Coat-A-Count kit (DPC, Los Angeles, CA, USA) 
validated for cattle by [16]
[17]
– 0.5–10 – [11]
0.21–0.34 – ELISA, validated for cattle (Immuno-Biological Labo-
ratories, Hamburg, Germany)
[18]
– 0.38–0.42 By EIA not specified [19]
– 0.59 (acyclic)
1.01 (cyclic)
RIA (RIAK-1 kit, BRIT, Navi Mumbai, India) [20]
– 0.27 (cyst)
1.15 (normal)
RIA (RIAK-1 kit, BRIT, Navi Mumbai, India) [21]
0.24 (heifer)
0.51 (cow)
– Insulin auto DELFIA (PerkinElmer Life and Analytical 
Science, Turku, Finland)
[22]
0.4–0.6 – EIA [23]
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Knowing that conditions occurring with hyperinsu-
linemia in vivo (metabolic syndrome, obesity or diabetes) 
impair fertility, the use of insulin in non-physiological 
doses should be used cautiously.
Insulin is used in IVP as its stimulatory effects on 
growth and proliferation have been seen as beneficial for 
the embryo development while possible negative con-
sequences for the epigenetic regulation and metabolic 
programming have been largely ignored. Research mod-
els should aim to work with concentrations as close as 
possible to the physiological conditions. Our pilot study 
does not support insulin degradation as a cause for using 
100–1000-fold higher insulin concentrations in in  vitro 
systems than can be found in vivo. Even if no statement 
about insulin activity can be made, the molecular struc-
ture of insulin seems to remain stable—as detectable 
by ELISA—even in media containing cysteine as in our 
maturation media based on TCM199. The gap between 
added and measurable concentrations in the INS10 
groups (Table 1) could be explained by the fact that the 
samples needed to be diluted for the ELISA to remain 
in the measurement window and this could lead to less 
accuracy especially as the sample size is low. As the con-
centrations are more stable in the group closer to physi-
ological concentrations (INS0.1), a general inactivation of 
insulin does not seem plausible.
However, different reaction and activity profiles in vivo 
and in vitro are plausible and need to be considered, as 
in  vitro models often aim to investigate consequences 
with new methods and expensive equipment where an 
insufficient concentration of the tested factor could cause 
problems to evaluate the data. More studies focusing on 
the molecular response of embryos to insulin should be 
aimed to obtain a better understanding of exposure to 
insulin during early embryonic development. Unnec-
essary high doses of insulin should be avoided as the 
biological consequences of an uncritical use of supra-
physiological doses are not clearly known.
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